Original Research
Published on 19 Jul 2024
Hypoxanthine in the microenvironment can enable thiopurine resistance in acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1440650
- 958 views
Type at least 3 characters
1,749 articles
Articles
Review
Published on 19 Jul 2024
Obstacles to global implementation of CAR T cell therapy in myeloma and lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1397613
- 1,807 views
- 1 citation
Mini Review
Published on 18 Jul 2024
Immune checkpoint inhibitors targeting PD-1/PD-L1 in the treatment of human lymphomas
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1420920
- 1,454 views
Systematic Review
Published on 18 Jul 2024
A systematic review and meta-analysis on utilizing anti-CD19 chimeric antigen receptor T-cell therapy as a second-line treatment for relapsed and refractory diffuse large B-cell lymphoma
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1407001
- 1,381 views
Case Report
Published on 18 Jul 2024
Familial 46, XY Disorder of Sexual Development identified in a Ph+BCR::ABL1P210+ Acute Lymphoblastic Leukemia septuagenarian female with RCBTB2::LPAR6 fusion gene: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1339737
- 748 views
Review
Published on 17 Jul 2024
Advancements in microenvironment-based therapies: transforming the landscape of multiple myeloma treatment
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1413494
- 1,170 views
Editorial
Published on 16 Jul 2024
Editorial: Biological and clinical implications of the mutational landscape in myeloproliferative neoplasms
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1454837
- 753 views
Case Report
Published on 15 Jul 2024
Case report: 18F-FDG PET/CT skeletal superscan-like in an adult patient with acute lymphoblastic leukemia
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1401453
- 778 views
Case Report
Published on 10 Jul 2024
Venetoclax in the treatment of secondary plasma cell leukemia with translocation t(11;14): a case report and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1390747
- 1,021 views
Mini Review
Published on 09 Jul 2024
“Off-The-Shelf” allogeneic chimeric antigen receptor T-cell therapy for B-cell malignancies: current clinical evidence and challenges
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1433432
- 1,985 views
- 2 citations
Review
Published on 05 Jul 2024
Targeting the CD47/SIRPα pathway in malignancies: recent progress, difficulties and future perspectives
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1378647
- 2,454 views
- 2 citations
Mini Review
Published on 03 Jul 2024
Overview of infectious complications among CAR T- cell therapy recipients
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1398078
- 2,271 views
- 1 citation
Original Research
Published on 02 Jul 2024
Pure red cell aplasia among ABO mismatched hematopoietic stem cell transplant recipients: a 13-years retrospective study and literature review
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1386670
- 1,216 views
Case Report
Published on 02 Jul 2024
Contrast-enhanced ultrasound findings of primary hepatic non-Hodgkin’s lymphoma: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1380392
- 802 views
Case Report
Published on 02 Jul 2024
The safety and efficacy of the re-administration of gilteritinib in a patient with FLT3-mutated R/R AML with CNS relapse: a case report
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1402970
- 1,044 views
Original Research
Published on 01 Jul 2024
Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis
in Hematologic Malignancies
Frontiers in Oncology
doi 10.3389/fonc.2024.1385987
- 1,086 views